FDA Drug Safety Labeling Changes

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Mon, 07/30/2018 - 16:40
#1
Jennifer Marie ...
Jennifer Marie Soto Meyer's picture
Offline
Last seen: 1 month 2 days ago
Joined: 01/11/2018 - 11:49
FDA Drug Safety Labeling Changes

I noted the FDA has recently updated the "Warnings and Precautions" section of the drug labeling for several paralytics to include a new subsection "Risk of Death Due to Medication Errors".

I don't recall seeing this subsection for other medications but perhaps I am mistaken. Has anyone noticed this subsection added to other agents?

I could easily see this subsection being applied to all high alert medications to some degree. Pondering if there are any potential future regulatory considerations. Also wondering if I have missed some information along the way regarding this subsection.

Top